Multi-Disciplinary Expert Perspective on the Management of Type 2 Inflammation-Driven Severe CRSwNP: A Brief Overview of Pathophysiology and Recent Clinical Insights

References

• Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(1):1–464. doi:10.4193/Rhin20.401
   Web of Science ®Google Scholar
• Al-Ahmad M, Alsaleh S, Al-Reefy H, et al. Expert opinion on biological treatment of chronic rhinosinusitis with nasal polyps in the Gulf region. J Asthma Allergy. 2022;15:1–12. doi:10.2147/JAA.S321017
   PubMed Web of Science ®Google Scholar
• Stevens WW, Lee RJ, Schleimer RP, et al. Chronic rhinosinusitis pathogenesis. J Allergy Clin Immunol. 2015;136(6):1442–1453. doi:10.1016/j.jaci.2015.10.009
   PubMed Web of Science ®Google Scholar
• Liu T, Sun Y, Bai W. The role of epigenetics in the chronic sinusitis with nasal polyp. Curr Allergy Asthma Rep. 2021;21(1):1–3. doi:10.1007/s11882-020-00976-8
   Web of Science ®Google Scholar
• Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe—an underestimated disease. A GA2LEN study. Allergy. 2011;66(9):1216–1223. doi:10.1111/j.1398-9995.2011.02646.x
   PubMed Web of Science ®Google Scholar
• Beule E. Epidemiology of chronic rhinosinusitis, selected risk factors, comorbidities, and economic burden. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2015;14:1–31.
   Google Scholar
• Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract. 2021;9(3):1133–1141. doi:10.1016/j.jaip.2020.09.063
   PubMed Web of Science ®Google Scholar
• Khan A, Vandeplas G, Huynh TMT, et al. The Global Allergy and Asthma European Network (GALEN) rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology. 2019;57(1):32–42. doi:10.4193/Rhin17.255
   PubMed Web of Science ®Google Scholar
• Seccia V, D’Amato M, Scioscia G, et al. Management of patients with severe asthma and chronic rhinosinusitis with nasal polyps: a multidisciplinary shared approach. J Pers Med. 2022;12(7):1096. doi:10.3390/jpm12071096
   PubMed Web of Science ®Google Scholar
• Chen S, Zhou A, Emmanuel B, et al. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis. Curr Med Res Opin. 2020;36(11):1897–1911. doi:10.1080/03007995.2020.1815682
   PubMed Web of Science ®Google Scholar
• Castillo JA, Plaza V, Rodrigo G, Julia B, Mullol J. Chronic rhinosinusitis with and without nasal polyps and rhinitis in adult asthma. Frequency distribution and relationship with asthma control and severity (the IRIS-ASMA study). Eur Respir J. 2013;42(Suppl 57):1.
   PubMedGoogle Scholar
• Bachert C, Bhattacharyya N, Desrosiers M, Khan AH. Burden of disease in chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2021;14:127–134. doi:10.2147/JAA.S290424
   PubMed Web of Science ®Google Scholar
• Vlaminck S, Acke F, Scadding GK, Lambrecht BN, Gevaert P. Pathophysiological and clinical aspects of chronic rhinosinusitis: current concepts. Front Allergy. 2021;2:741788. doi:10.3389/falgy.2021.741788
   PubMedGoogle Scholar
• Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2015;135(3):626–635. doi:10.1016/j.jaci.2014.11.001
   PubMed Web of Science ®Google Scholar
• Gandhi NA, Bennett BL, Graham NM, et al. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15(1):35–50. doi:10.1038/nrd4624
   PubMed Web of Science ®Google Scholar
• Altrichter S, Fok JS, Jiao Q, et al. Total IgE as a marker for chronic spontaneous urticaria. Allergy Asthma Immunol Res. 2021;13(2):206–218. doi:10.4168/aair.2021.13.2.206
   PubMed Web of Science ®Google Scholar
• Ramirez GA, Yacoub MR, Ripa M, et al. Eosinophils from physiology to disease: a comprehensive review. Biomed Res Int. 2018;2018:9095275. doi:10.1155/2018/9095275
   PubMed Web of Science ®Google Scholar
• McLeod JJA, Baker B, Ryan JJ. Mast cell production and response to IL-4 and IL-13. Cytokine. 2015;3:1–5.
   Google Scholar
• Toppila-Salmi S, et al. In preparation.
   Google Scholar
• De Greve G, Hellings PW, Fokkens WJ, et al. Endotype driven treatment in chronic upper airway diseases. Clin Transl Allergy. 2017;7(1):22. doi:10.1186/s13601-017-0157-8
   PubMedGoogle Scholar
• Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449–1456. doi:10.1016/j.jaci.2015.12.1324
   PubMed Web of Science ®Google Scholar
• Du K, Wang X. Regional Difference (chapter). In: Chronic Rhinosinusitis: The Mucosal Concept. Springer; 2022:181–185.
   Google Scholar
• Shin HW, Kim DK, Park MH, et al. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2015;135(6):1476–1485. doi:10.1016/j.jaci.2015.01.003
   PubMed Web of Science ®Google Scholar
• Ryu G, Kim DW. Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis. Curr Opin Allergy Clin Immunol. 2020;20(1):1–8. doi:10.1097/ACI.0000000000000588
   PubMed Web of Science ®Google Scholar
• Ta NH. Will we ever cure nasal polyps? Ann Royal Coll Surg Engl. 2019;101(1):35–39. doi:10.1308/rcsann.2018.0149
   PubMed Web of Science ®Google Scholar
• DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2017;127(3):550–555. doi:10.1002/lary.26391
   PubMed Web of Science ®Google Scholar
• Wautlet AD, Bachert C, Desrosiers M, et al. The management of chronic rhinosinusitis with nasal polyps (CRSwNP) with biologics. J Allergy Clin Immunol. 2023;S2213–S298(23):00539.
   Google Scholar
• Bhatt SP, Rabe K, Hanania NA, et al. Dupilumab for COPD with Type 2 inflammation indicated by eosinophil counts. N Engl J Med. 2023;389(3):205–214. doi:10.1056/NEJMoa2303951
   PubMed Web of Science ®Google Scholar
• Patel GB, Peters AT. The role of biologics in chronic rhinosinusitis with nasal polyps. Ear Nose Throat J. 2021;100(1):44–47. doi:10.1177/0145561320964653
   PubMed Web of Science ®Google Scholar
• Lyly A, Genberg E, Kauppi P, et al. Real-life experience of biologic treatment for asthma on chronic rhinosinusitis: a Finnish cohort. Int Arch Allergy Immunol. 2023;184(2):149–160. doi:10.1159/000526365
   PubMed Web of Science ®Google Scholar
• Johansson L, Åkerlund A, Melén I, Holmberg K, Bende M. Prevalence of nasal polyps in adults: the Skovde population‐based study. Ann Otol Rhinol Laryngol. 2003;112(7):625–629. doi:10.1177/000348940311200709
   PubMed Web of Science ®Google Scholar
• Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin oral intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population‐based study. Int J Epidemiol. 1999;28(4):717–722. doi:10.1093/ije/28.4.717
   PubMed Web of Science ®Google Scholar
• Bico B, Cleverstam E, Sahlstrand P Surgery of patients with nasal polyposis in Sweden – a register study.
   Google Scholar
• Toppila‐Salmi S, Hällfors J, Aakko J, et al. The burden of chronic rhinosinusitis with nasal polyps and its relation to asthma in Finland. Clin Transl Allergy. 2022:e12200. doi:10.1002/clt2.12200
   PubMed Web of Science ®Google Scholar
• Nuutinen M, Lyly A, Virkkula P, et al. The relative proportion of comorbidities among rhinitis and rhinosinusitis patients and their impact on visit burden. Clin Transl Allergy. 2022;12(7). doi:10.1002/clt2.12181
   PubMed Web of Science ®Google Scholar
• Backer V, Cardell LO, Lehtimäki L, et al. Multidisciplinary approaches to identifying and managing global airways disease: expert recommendations based on qualitative discussions. Front Allergy. 2023;4:1052386. doi:10.3389/falgy.2023.1052386
   PubMedGoogle Scholar
• Håkansson K, Bachert C, Konge L, et al. Airway inflammation in chronic rhinosinusitis with nasal polyps and asthma: the united airways concept further supported. PLoS One. 2015;10:e0127228.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Viskens AS, Backer V, et al. EPOS/EUFOREA update on indication and evaluation of biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology. 2023;61:3.
   Web of Science ®Google Scholar
• Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021;147(1):29–36. doi:10.1016/j.jaci.2020.11.013
   PubMed Web of Science ®Google Scholar
• Lilja MJ, Koskinen A, Virkkula P, et al. Factors affecting the control of chronic rhinosinusitis with nasal polyps: a comparison in patients with or without NERD. Allergy Rhinol. 2021;12:1–10. doi:10.1177/21526567211003844
   Web of Science ®Google Scholar
• Penttilä E, Sillanpää S, Vento SI, et al. Eosinophilia, asthma, NERD and the use of oral corticosteroids predict uncontrolled chronic rhinosinusitis with nasal polyps after surgery. Asian Pac J Allergy Immunol. 2021. doi:10.12932/AP-310321-1102
   Google Scholar
• Fujieda S, Imoto K, Kato Y, et al. Eosinophilic chronic rhinosinusitis. Allergol Int. 2019;68(4):403–412. doi:10.1016/j.alit.2019.07.002
   PubMed Web of Science ®Google Scholar
• Brescia G, Marioni G, Franchella S, et al. A prospective investigation of predictive parameters for post-surgical recurrences in sinonasal polyposis. Eur Arch Otorhinolaryngol. 2016;273(3):655–660. doi:10.1007/s00405-015-3598-5
   PubMed Web of Science ®Google Scholar
• Swedish guidelines for treatment with biological drugs in chronic rhinosinusitis with nasal polyps (CRSwNP) with type 2 inflammation. Available from: Riktlinjer-for-behandling-med-biologiska-lakemedel-vid-kronisk-rinosinuit-med-naspolyper-CRSwNP-med-typ-2-inflammation.pdf.(svenskonh.se). Accessed June 2023.
   Google Scholar
• Suositus biologisesta lääkehoidosta - Consociatio Rhinologica Fennica r.y. Available from: (rinologiyhdistys.fi). Accessed August, 2023.
   Google Scholar
• De Corso E, Settimi S, Montuori C, et al. How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review. Acta Otolaryngol Ital. 2023;43(Suppl.1):1.
   Google Scholar
• Wu AW, Ting JY, Platt MP, et al. Factors affecting time to revision sinus surgery for nasal polyps: a 25-year experience. Laryngoscope. 2014;124(1):29–33. doi:10.1002/lary.24213
   PubMed Web of Science ®Google Scholar
• Kim DH, Lim JY, Jang JY, et al. Distinct subsets of innate lymphoid cells in nasal polyp. Allergol Int. 2023;72(1):151–160. doi:10.1016/j.alit.2022.06.007
   PubMed Web of Science ®Google Scholar
• Gray ST, Phillips KM, Hoehle LP, et al. The 22-item Sino-Nasal Outcome Test accurately reflects patient-reported control of chronic rhinosinusitis symptomatology. Int Forum Allergy Rhinol. 2017;7(10):945–951. doi:10.1002/alr.21992
   PubMed Web of Science ®Google Scholar